We are live on ! Find out more
SCR

SIMCERE PHARMACEUTICAL GROUP, ADS
SCR

Delisted

SCR was delisted on the 23rd of December, 2013.

Back to rankings

21 hedge funds and large institutions have $16.6M invested in SIMCERE PHARMACEUTICAL GROUP, ADS in 2013 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

80% less call options, than puts

Call options by funds: $133K | Put options by funds: $653K

Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
–
Reduced
–
Closed
–
Calls
$133K
Puts
$653K
Net Calls
-$520K
Net Calls Change
-$520K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SCR Hedge Fund Activity: Q2 2013 in Review

21 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) for Q2 2013, worth a combined $16.6M.

Buyers outnumbered sellers: 21 funds opened new SCR positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.

  • 21 institutional investors held SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6M of SIMCERE PHARMACEUTICAL GROUP, ADS stock for Q2 2013.
  • 21 funds opened new SIMCERE PHARMACEUTICAL GROUP, ADS positions in Q2 2013 and 0 closed out, a net change of +21 holders.

Based on aggregated 13F filings for Q2 2013.